KC1036 Clinical Trials
6 recruitingDrug
Phase 24Phase 12Phase 31
Showing 1–6 of 6 trials
Recruiting
Phase 2
KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer
Esophageal Squamous Cell Carcinoma (ESCC)
Beijing Konruns Pharmaceutical Co., Ltd.60 enrolled1 locationNCT07481058
Recruiting
Phase 2
A Study of KC1036 in Patients with Advanced Thymic Tumors
Thymic Tumors
Beijing Konruns Pharmaceutical Co., Ltd.30 enrolled2 locationsNCT05683886
Recruiting
Phase 1
A Study of KC1036 in Patients with Advanced Solid Tumors
Advanced Solid Tumors
Beijing Konruns Pharmaceutical Co., Ltd.207 enrolled3 locationsNCT04387916
Recruiting
Phase 1Phase 2
To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors
Digestive System Tumors
Beijing Konruns Pharmaceutical Co., Ltd.133 enrolled13 locationsNCT05260385
Recruiting
Phase 2
A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma
Ewing Sarcoma
Beijing Konruns Pharmaceutical Co., Ltd.30 enrolled1 locationNCT06564272
Recruiting
Phase 3
A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer
Esophageal Squamous Cell Carcinoma
Beijing Konruns Pharmaceutical Co., Ltd.490 enrolled1 locationNCT06194734